Yulong Li

机构：King University, McGovern Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Sichuan University, Central Military Commission, West China Hospital of Sichuan University, Sichuan Provincial Architectural Design and Research Institute (China), Beijing Biocytogen (China), Chinese Institute for Brain Research, Chengdu University, Tongren University, Active Technologies (Italy), Center for Life Sciences, Fu Wai Hospital · ORCID：0000-0002-9166-9919

发表论文 570 篇 · 总被引 20211 次 · h-index 71

代表论文

• Adenosine signalling drives antidepressant actions of ketamine and ECT (2025 · Nature · 被引 33)
• SPT-3G D1: Constraints on inflationary gravitational waves with two years of SPT-3G data (2025 · Physical review. D/Physical review. D. · 被引 11)
• HSP70 Interactome‐Mediated Proteolysis Targeting Chimera (HSP70‐PROTAC) for Ferroptosis‐Driven Cancer Treatment (2025 · Advanced Science · 被引 7)
• Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment (2026 · Nature Chemical Biology · 被引 3)
• Global, regional, and national burden of lung cancer attributable to second-hand smoke from 1990 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 (2025 · Frontiers in Oncology · 被引 2)
• Red-shifted GRAB acetylcholine sensors for multiplex imaging in vivo (2026 · Nature Neuroscience · 被引 1)